Pricing, Reimbursement & Market Access Experts - Pharmaceutical and Biotech industries

Tailoring the right team is crucial to project success.

Our consultants are an experienced, highly educated multidisciplinary team with broad disease area backgrounds and extensive, practical market access knowledge, who are curious about and engaged in what they do; your key contact will be a senior member of the consultancy team. In addition, all work is reviewed by our quality review team, drawn from senior leadership roles in pharmaceutical and biotech companies, the payer community, and from academia; our quality review team oversees all work in progress to ensure that it answers your needs and tells the whole story.

International experts group

This agile team has organized, moderated, and facilitated more than 55 advisory boards and expert panels over the past 3 years, and maintains strong working relationships with more than 700 payer and clinician advisors.

Country-specific experts

This team comprises consultants, many of whom are native-language speakers, with specific knowledge of HTA/P&R processes and healthcare systems in core and key emerging markets, ensuring that project analysis and insights are framed appropriately within the rapidly evolving P&R landscape.

Ethics committee

We have a unique program approval in place with a duly constituted university ethics committee, ensuring that studies are methodologically rigorous and meet the requirements for publication in peer-reviewed journals.

We are always looking for people who will deliver first-class work while thriving in our friendly office culture.
UK (HQ) +44 (0)1252 786284
US +1 (415) 655 6798

Company registration number: 05893400

Follow us

Terms and conditions
Privacy statement
Cookie policy